ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,859,606 | -22.0% | 68,519 | -11.6% | 0.29% | -24.0% |
| Q2 2023 | $2,382,627 | +63.8% | 77,509 | +110.6% | 0.38% | +55.5% |
| Q4 2022 | $1,454,178 | +17.2% | 36,796 | +19.1% | 0.25% | +6.9% |
| Q3 2022 | $1,241,000 | +38.4% | 30,896 | +34.2% | 0.23% | -6.1% |
| Q1 2022 | $897,000 | +10.9% | 23,024 | +13.4% | 0.25% | +12.3% |
| Q4 2021 | $809,000 | +137.2% | 20,300 | +115.5% | 0.22% | +135.5% |
| Q3 2021 | $341,000 | -58.4% | 9,422 | -52.8% | 0.09% | -58.8% |
| Q2 2021 | $819,000 | – | 19,969 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |